The UT-HIP TPI Project continues to advance key priorities in partnership with TPI Executive Leadership and the Board. In June 2026, the team delivered an updated TPI Business Plan to the Texas Legislature, achieving a major project milestone.
The analytics team has completed foundational analyses using more than 100 million prescription drug and medical claims from participating state agencies and systems, including the Teacher Retirement System (TRS), Employees Retirement System (ERS), UT System (UTS), and Texas A&M University (TAMU). The next phase will focus on advanced modeling and ongoing cost analysis.
Clinical and industry work is also progressing. Five subspecialty clinical workgroups have completed their work, with four additional workgroups underway through fall 2026 and more planned for 2027. In parallel, research and analysis are advancing across prescription drug manufacturing, pharmacy access, drug quality, and shortage management.
